NCT05830760View on ClinicalTrials.gov

Expression of Sodium-glucose Co-transporter 2 in Human Heart

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Aortic Valve Stenosis
Interventions
BIOLOGICAL

Myocardium biopsy

The expression of SGLT2 on small myocardium specimens harvested during aortic valve replacement operation in patients with aortic stenosis

Trial Locations (1)

67098

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT05830760 - Expression of Sodium-glucose Co-transporter 2 in Human Heart | Biotech Hunter | Biotech Hunter